Press release
Anti-Inflammatory Therapeutics Market: Steady Growth, Rising Prevalence of Inflammatory Diseases, and Advancements in Therapies Set to Drive Global Market Towards $144.05 Billion by 2029
Rise in chronic diseases and aged population, innovative therapies, government initiatives, and key trends like AI in drug discovery are creating waves in the global anti-inflammatory therapeutics market.What Is The Projected Market Size Of The Global Anti-Inflammatory Therapeutics Global Market Report 2025 And Its Growth Rate?
• The anti-inflammatory therapeutics market is projected to grow steadily from $114.71 billion in 2024 to $118.44 billion in 2025 at a compound annual growth rate (CAGR) of 3.3%.
• The market size is expected to see significant growth in the coming years, reaching $144.05 billion in 2029 at a CAGR of 5.0%.
What Is Driving The Growth In The Anti-Inflammatory Therapeutics Global Market Report 2025?
Increase in the prevalence of both inflammatory bowel disease (IBD) and autoimmune disorders is propelling the growth of the anti-inflammatory therapeutics market. IBD, a chronic illness causing inflammation of the gastrointestinal tract, has seen its incidence steady at 10.9 per 100,000 person-years with a prevalence of 721 per 100,000 people according to Oxford University Press in 2023. Moreover, the rising number of autoimmune disorders, wherein the immune system mistakenly attacks the body's own healthy cells and tissues, has been a significant factor in driving the market's the growth. As per the Guardian Media Group, in 2022, there were 4 million people in the UK suffering from such disorders, and globally, it is estimated that it rises by 3% to 9% each year.
Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
Who Are the Key Players Driving Anti-Inflammatory Therapeutics Global Market Report 2025 Growth?
• Pfizer Inc.
• Johnson and Johnson Limited
• F. Hoffmann-La Roche Ltd.
• Merck and Co. Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi-Aventis LLC.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• GlaxoSmithKline plc.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Co Ltd.
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Biogen Inc.
• Daiichi Sankyo Company Limited
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Limited
• Otsuka Pharmaceutical Co. Ltd.
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Cipla Inc.
• Zydus Lifesciences Ltd.
• Lupin Limited
• Torrent Pharmaceuticals Ltd.
What Are The Key Trends In The Anti-Inflammatory Therapeutics Global Market Report 2025?
Key trends include:
• Advancements in immunotherapy
• Utilization of artificial intelligence (AI) and machine learning (ML) in drug discovery
• Expansion of indications
What Are The Segments Of The Global Anti-Inflammatory Therapeutics Global Market Report 2025?
The anti-inflammatory therapeutics market is segmented by:
1) Drug Class:
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Corticosteroids
• Anti-Inflammatory Biologics
2) Indication
• Arthritis
• Respiratory Diseases
• Multiple Sclerosis
• Psoriasis
• Inflammatory Bowel Diseases
• Other Inflammatory Diseases
3) Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Distribution
Which Region Leads The Anti-Inflammatory Therapeutics Global Market Report 2025?
North America was the largest region in the anti-inflammatory therapeutics market in 2024, while Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the report for swift delivery: https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report
What Is Covered In The Anti-Inflammatory Therapeutics Global Market Report 2025 Global Market Report?
- Market Size Analysis: Analyze the Anti-Inflammatory Therapeutics Global Market Report 2025 size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Anti-Inflammatory Therapeutics Global Market Report 2025 for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Anti-Inflammatory Therapeutics Global Market Report 2025 growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Anti-Inflammatory Therapeutics Global Market Report 2025.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report: https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Inflammatory Therapeutics Market: Steady Growth, Rising Prevalence of Inflammatory Diseases, and Advancements in Therapies Set to Drive Global Market Towards $144.05 Billion by 2029 here
News-ID: 3845840 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Inflammatory
Inflammatory Myositis Market Massive Growth opportunity Ahead
Introduction
Inflammatory myositis is a group of rare autoimmune disorders characterized by chronic inflammation of skeletal muscles, leading to progressive muscle weakness, fatigue, and functional disability. The spectrum includes polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), immune-mediated necrotizing myopathy (IMNM), and overlap syndromes. These disorders can also involve other organs, most notably the lungs (interstitial lung disease), skin, heart, and joints, complicating disease management.
Historically, corticosteroids and conventional immunosuppressants have formed…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
The Anti-Inflammatory Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Anti-Inflammatory Therapeutics Market Size and Projected Growth Rate?
The market size of anti-inflammatory therapeutics has shown a consistent growth in the past few years. The market is projected to expand from $114.71…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
What market dynamics are playing a key role in accelerating the growth of the anti-inflammatory therapeutics market?
As inflammatory bowel disease becomes more commonplace, it is predicted to encourage progress in the anti-inflammatory therapeutics market. Characterized as a long-term condition causing inflammation of the digestive tract, inflammatory bowel disease (IBD) is effectively managed with the usage of anti-inflammatory therapeutics. These treatments are central in the control of Crohn's disease via decreasing…
Anti-Inflammatory Activity Enzyme Manufacturer | Pearlzyme Inc
Pearlzyme Inc. is a South Korean company that manufactures anti inflammatory activity enzymes. This anti-inflammatory activity enzyme boosts the animal's immune system against infection and increases milk lactation.
Pearlzyme Inc. is committed to providing high-quality products and services to its customers. The company has a team of experienced scientists and engineers who are constantly working to develop new and innovative products. Pearlzyme Inc. is also committed to sustainable development and is…
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant…
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.
Get the sample…
